Correlation Between Protalix Biotherapeutics and Innate Pharma
Can any of the company-specific risk be diversified away by investing in both Protalix Biotherapeutics and Innate Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protalix Biotherapeutics and Innate Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protalix Biotherapeutics and Innate Pharma, you can compare the effects of market volatilities on Protalix Biotherapeutics and Innate Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protalix Biotherapeutics with a short position of Innate Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protalix Biotherapeutics and Innate Pharma.
Diversification Opportunities for Protalix Biotherapeutics and Innate Pharma
-0.8 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Protalix and Innate is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Protalix Biotherapeutics and Innate Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innate Pharma and Protalix Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protalix Biotherapeutics are associated (or correlated) with Innate Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innate Pharma has no effect on the direction of Protalix Biotherapeutics i.e., Protalix Biotherapeutics and Innate Pharma go up and down completely randomly.
Pair Corralation between Protalix Biotherapeutics and Innate Pharma
Considering the 90-day investment horizon Protalix Biotherapeutics is expected to generate 0.88 times more return on investment than Innate Pharma. However, Protalix Biotherapeutics is 1.14 times less risky than Innate Pharma. It trades about 0.1 of its potential returns per unit of risk. Innate Pharma is currently generating about -0.08 per unit of risk. If you would invest 114.00 in Protalix Biotherapeutics on August 28, 2024 and sell it today you would earn a total of 57.00 from holding Protalix Biotherapeutics or generate 50.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Protalix Biotherapeutics vs. Innate Pharma
Performance |
| Timeline |
| Protalix Biotherapeutics |
| Innate Pharma |
Protalix Biotherapeutics and Innate Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protalix Biotherapeutics and Innate Pharma
The main advantage of trading using opposite Protalix Biotherapeutics and Innate Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protalix Biotherapeutics position performs unexpectedly, Innate Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innate Pharma will offset losses from the drop in Innate Pharma's long position.| Protalix Biotherapeutics vs. Corvus Pharmaceuticals | Protalix Biotherapeutics vs. Aldeyra | Protalix Biotherapeutics vs. Checkpoint Therapeutics | Protalix Biotherapeutics vs. Cidara Therapeutics |
| Innate Pharma vs. Eliem Therapeutics | Innate Pharma vs. HCW Biologics | Innate Pharma vs. Inhibrx | Innate Pharma vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |